6. RedHill Biopharma Ltd. (NASDAQ:RDHL)
Closing Share Price $0.5000
Daily Increase 4.17%
Market Cap $3.04 Million
RedHill Biopharma Ltd. (NASDAQ: RDHL) focuses on gastrointestinal and infectious diseases. Recent announcements describe a restructuring of its commercial drug portfolio, including the sale of one business and the acquisition of commercialization rights to other gastrointestinal products. The company therefore offers a business-transition story alongside its pharmaceutical exposure.
The stock gained 4.17% to finish at $0.5000. Its score of 8.34 placed it slightly ahead of the previous entry, while its reported market capitalization was approximately $3.04 million. That very small market value makes the details of its capital structure and operating commitments particularly relevant.
The quote provider reported a trailing net loss of approximately $2.40 million, with no trailing revenue figure displayed. The more useful question is how the revised portfolio could affect future sales, expenses, and cash generation. For readers screening cheap pharmaceutical stocks, a low share price is an invitation to investigate the business—not evidence that the transition will succeed.
YOU MUST READ THIS: Top 10 Medical Robotics Stocks to Buy Today
Click here to continue reading and checkout the Top 5 Healthcare Stocks Under $10 to Watch Now.
Disclosure: No relevant interests to disclose. This article was originally published on BioTech HealthX.
